TEVA PHARMACDRNTEVA PHARMACDRNTEVA PHARMACDRN

TEVA PHARMACDRN

No trades
See on Supercharts

T1EV34 fundamentals

An in-depth look to TEVA PHARMACDRN operating, investing, and financing activities

T1EV34 free cash flow for Q2 24 is 1.77 B BRL. For 2023, T1EV34 free cash flow was 11.45 B BRL and operating cash flow was 14.05 B BRL.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BRL
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth